(Q40482636)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

review article

1 reference

title

Contemporary approaches in medical management of patients with stable coronary artery disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

author name string

E V Carbajal

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

P C Deedwania

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

language of work or name

1 reference

1 September 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

Medical Clinics of North America

23 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

volume

79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

page(s)

1063-1084

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

New insights into the management of myocardial ischemia. Overview

23 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

beta-Adrenoceptor blocking activity and duration of action of pindolol and propranolol in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Coronary artery syndromes after sudden propranolol withdrawal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Rationale for intermittent nitrate therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effect of nitroglycerin and nifedipine on subendocardial perfusion in the presence of a flow-limiting coronary stenosis in the awake dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Nifedipine-induced hypotension and myocardial ischemia in refractory angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effects of calcium-channel blocking agents on left ventricular diastolic function in hypertrophic cardiomyopathy and in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Angina caused by reduced vasodilator reserve of the small coronary arteries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Silent myocardial ischemia in patients with a defective anginal warning system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Global and regional left ventricular ejection fraction abnormalities during exercise in patients with silent myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

The Nifedipine-Total Ischemia Awareness Program: a national survey of painful and painless myocardial ischemia including results of antiischemic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Myocardial ischemia during ergonovine testing: different susceptibility to coronary vasoconstriction in patients with exertional and variant angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Failure of captopril to prevent nitrate tolerance in congestive heart failure secondary to coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Amlodipine reduces transient myocardial ischemia in patients with coronary artery disease: double-blind Circadian Anti-Ischemia Program in Europe (CAPE Trial).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Silent myocardial ischaemia due to mental stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Transient ST-segment depression as a marker of myocardial ischemia during daily life

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Prevalence and patterns of silent myocardial ischemia during daily life in stable angina patients receiving conventional antianginal drug therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Silent ischemia during daily life is an independent predictor of mortality in stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Pathophysiology of silent myocardial ischemia during daily life. Hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Intermittent transdermal nitroglycerin therapy in the treatment of chronic stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effects of nitroglycerin at therapeutic doses on platelet aggregation in unstable angina pectoris and acute myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Experimental pain measurement in patients with asymptomatic myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Possible mechanisms of nitrate tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effects of preload on the transmural distribution of perfusion and pressure-flow relationships in the canine coronary vascular bed

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Myocardial ischemia--silent or symptomatic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

The effects of organic nitrates on prostacyclin biosynthesis and platelet function in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Nitrate tolerance. A review of the evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Avoidance of tolerance and lack of rebound with intermittent dose titrated transdermal glyceryl trinitrate. The Transdermal Nitrate Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Vasoconstriction of stenotic coronary arteries during dynamic exercise in patients with classic angina pectoris: reversibility by nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Trends in acute myocardial infarction and coronary heart disease death in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Decline in coronary heart disease mortality. Old questions and new facts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Safety and compatibility of betaxolol hydrochloride combined with diltiazem or nifedipine therapy in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Importance of generalized defective perception of painful stimuli as a cause of silent myocardial ischemia in chronic stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effect of glyceryl trinitrate on echocardiographic left ventricular dimensions during exercise in the upright position

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Atherosclerosis influences the vasomotor response of epicardial coronary arteries to exercise

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Silent ischemia as a marker for early unfavorable outcomes in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Efficacy, safety and duration of nitrate-free interval to prevent tolerance to transdermal nitroglycerin in effort angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Optimal control of myocardial ischaemia: the benefit of a fixed combination of atenolol and nifedipine in patients with chronic stable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Comparative pharmacology of calcium antagonists: Nifedipine, verapamil and diltiazem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Diltiazem-induced blockade of sympathetically mediated constriction of normal and diseased coronary arteries: lack of epicardial coronary dilatory effect in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effects of titrated beta blockade (metoprolol) on silent myocardial ischemia in ambulatory patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Efficacy of transdermal glyceryl trinitrate in the treatment of chronic stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Response of angina and ischemia to long-term treatment in patients with chronic stable angina: A double-blind randomised individualized dosing trial of nifedipine, propranolol and their combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Potentiation of coronary vasoconstriction by beta-adrenergic blockade in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effects of treatment strategies to suppress ischemia in patients with coronary artery disease: 12-week results of the Asymptomatic Cardiac Ischemia Pilot (ACIP) study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Acute and sustained effects of isosorbide 5-mononitrate in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Platelets, vasoconstriction, and nitroglycerin during arterial wall injury. A new antithrombotic role for an old drug

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Transdermal nitroglycerin in angina pectoris: efficacy of intermittent application

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Phenomenon of nitrate tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effects of a calcium-entry blocker (diltiazem) on regional myocardial flow and function during exercise in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Pathogenesis of angina pectoris and role of nitrates in relief of myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Asymptomatic ischemia in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Large coronary arteries in humans are responsive to changing blood flow: an endothelium-dependent mechanism that fails in patients with atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Prognostic significance of silent myocardial ischemia in patients with unstable angina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Mechanism of propranolol withdrawal phenomena

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Nitrate therapy in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Transdermal nitroglycerin in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Morning increase in ambulatory ischemia in patients with stable coronary artery disease. Importance of physical activity and increased cardiac demand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Comparison of buccal nitroglycerin and oral isosorbide dinitrate for nitrate tolerance in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Counter-regulatory responses to continuous and intermittent therapy with nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effect of therapy with an angiotensin-converting enzyme inhibitor on hemodynamic and counterregulatory responses during continuous therapy with nitroglycerin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effect of intervals between doses on the development of tolerance to isosorbide dinitrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Neurohormonal activation during nitrate therapy: a possible mechanism for tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Elevated pain threshold in patients with effort-induced angina pectoris and asymptomatic myocardial ischemia during exercise test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Comparison of selective (beta 1) and nonselective (beta 1 and beta 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

The effects of slow channel blockers and beta blockers on atrioventricular nodal conduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Myocardial ischemia caused by distal coronary-artery constriction in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Relation and independence of angina pectoris and sudden death in persons with coronary atherosclerotic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Antianginal effects of nitroglycerin patches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Prognostic importance of myocardial ischemia detected by ambulatory monitoring in patients with stable coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Regular physical exercise and low-fat diet. Effects on progression of coronary artery disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Pathophysiology of ischemia in patients with coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Hypercholesterolemia causes generalized impairment of endothelium-dependent relaxation to aggregating platelets in porcine arteries.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Induction and circumvention of nitrate tolerance applying different dosage intervals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Endothelium-dependent relaxation and experimental atherosclerosis in the rabbit aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Reduced thiols and the effect of intravenous nitroglycerin on platelet aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Early detection of silent ischaemic heart disease by 24-hour electrocardiographic monitoring of active subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Comparison of propranolol, diltiazem, and nifedipine in the treatment of ambulatory ischemia in patients with stable angina. Differential effects on ambulatory ischemia, exercise performance, and anginal symptoms. The ASIS Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Role of nitrates in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Nitrate therapy for myocardial ischemic syndrome: current perspectives including tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Prevention and reversal of tolerance to nitroglycerine with N-acetylcysteine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Comparison of mortality and myocardial infarction rates in stable angina pectoris with and without ischemic episodes during daily activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Retardation and arrest of progression or regression of coronary artery disease: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Comparison of nifedipine gastrointestinal therapeutic system and atenolol on antianginal efficacies and exercise hemodynamic responses in stable angina pectoris

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Effects of asymptomatic ischemia on long-term prognosis in chronic stable coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-7125%2816%2930020-7

10.1016/S0025-7125(16)30020-7

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7674685%20AND%20SRC:MED&resulttype=core&format=json

23 October 2019

1 reference